肿瘤预防与治疗2017，Vol.30Issue(5)：390-395,6.DOI:10.3969/j.issn.1674-0904.2017.05.012
EML4-ALK融合基因重排对晚期非小细胞肺癌诊断及治疗价值
The Progress in Diagnosis and Treatment of Advanced Non-Small Cell Lung Cancer with EML4-ALK Fusion Gene Rearrangement Positive
摘要
Abstract
Lung cancer is most popular malignant tunors by both morbidity and mortality,non-small cell counts for 80％.Studies have shown that EGFR and ALK are the main driving genes for non-small cell lung cancer.In recent years,targeted drugs targeting these two targets have achieved remarkable curative effect and have been widely concerned.In this paper,we reviewed the related studies of EML4-ALK fusion gene rearranged positive patients.关键词
非小细胞肺癌/EML4-ALK融合基因/靶向治疗Key words
Non-small cell lung cancer/EML4-ALK fusion gene/Targeted therapy分类
医药卫生引用本文复制引用
姚文秀,李秀娟,黄欢..EML4-ALK融合基因重排对晚期非小细胞肺癌诊断及治疗价值[J].肿瘤预防与治疗,2017,30(5):390-395,6.基金项目
四川省卫计委课题(编号:2012JY0058) （编号:2012JY0058）
